These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3798908)

  • 1. [Production of a vaccine against hepatitis B in Africa: the problems and prospects].
    Nasidi A; Herry TO
    Vopr Virusol; 1986; 31(5):591-4. PubMed ID: 3798908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of plasma-derived hepatitis B vaccine production.
    Mahoney RT
    Vaccine; 1990 Aug; 8(4):397-401. PubMed ID: 2144390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccine: clinical experience.
    Tron F
    IARC Sci Publ; 1984; (63):279-95. PubMed ID: 6242147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Active immunoprophylaxis of type B viral hepatitis. Evaluation of the effectiveness of HEVAC-B vaccine in a population at risk].
    Tarocco RP; Faro G; Sargiotto A; Visconti C
    Minerva Med; 1987 Aug; 78(16):1233-41. PubMed ID: 2957614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update after 16 years of hepatitis B vaccination in South Africa.
    Burnett RJ; Kramvis A; Dochez C; Meheus A
    Vaccine; 2012 Sep; 30 Suppl 3():C45-51. PubMed ID: 22939021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The relation of infection with the hepatitis B-agent to primary hepatic carcinoma (author's transl)].
    Blumberg BS; Larouzé B; London WT; Werner B; Hesser JE; Millman I; Saimot G; Payet M
    Leber Magen Darm; 1976 Dec; 6(6):309-15. PubMed ID: 190499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B vaccine in developing countries: problems and prospects.
    Ayoola EA
    IARC Sci Publ; 1984; (63):297-305. PubMed ID: 6242148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation of infection with the hepatitis B agent to primary hepatic carcinoma.
    Blumberg BS; Larouzé B; London WT; Werner B; Hesser JE; Millman I; Saimot G; Payet M
    Am J Pathol; 1975 Dec; 81(3):669-82. PubMed ID: 174434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for prevention and control of hepatitis B and hepatocellular carcinoma.
    Sobeslavsky O
    IARC Sci Publ; 1984; (63):271-8. PubMed ID: 6100274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus and the control of hepatocellular carcinoma.
    Blumberg BS
    IARC Sci Publ; 1984; (63):243-61. PubMed ID: 6100273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of hepatitis B virus vaccine in Africa: rationale and practical approaches for effective utilization.
    Prince AM
    IARC Sci Publ; 1984; (63):337-54. PubMed ID: 6242151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral hepatitis: global goals for vaccination.
    Lavanchy D
    J Clin Virol; 2012 Dec; 55(4):296-302. PubMed ID: 22999800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing hepatitis B and hepatocellular carcinoma in South Africa: The case for a birth-dose vaccine.
    Spearman CW; Sonderup MW
    S Afr Med J; 2014 Jul; 104(9):610-2. PubMed ID: 25212400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of a low-cost hepatitis B vaccine in the South African Expanded Programme on Immunisation.
    Aspinall S; Kocks DJ
    S Afr Med J; 1998 Jan; 88(1):36-9. PubMed ID: 9539933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening costs in a hepatitis B vaccine program.
    West KH; Yuras RJ
    JEMS; 1990 Aug; 15(8):40-3. PubMed ID: 10105760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Forecasting strategies of hepatitis B vaccination based on decision tree model].
    Zhang SX
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Aug; 10(4):193-7. PubMed ID: 2509074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthetic vaccines for immunization against infection with hepatitis B virus].
    Horejsí J
    Cas Lek Cesk; 1989 Feb; 128(7):193-7. PubMed ID: 2524258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D; Suvatte V; Assateerawatts A
    Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.